As Sales Slip, Merck & Co. Plans 7,200 Job Cuts

Facing lower sales of Vytorin, Singulair and Gardasil, on top of recent pipeline disappointments, Merck implements a new restructuring initiative.

More from Archive

More from Pink Sheet